Overall, participants with baseline obesity had higher disease activity and smaller reduction in disease activity scores over time from week 8 throughout week 48 compared with participants with BMI <30 kg/m2 as assessed by CDAI, SDAI and DAS28-CRP (figure 2A,B). Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.